MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
When do Midazolam Hydrochloride (autoinjector) patents expire, and when can generic versions of Midazolam Hydrochloride (autoinjector) launch?
Midazolam Hydrochloride (autoinjector) is a drug marketed by Rafa Labs Ltd and is included in one NDA.
The generic ingredient in MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Midazolam Hydrochloride (autoinjector)
A generic version of MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) was approved as midazolam hydrochloride by FRESENIUS KABI USA on June 20th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)?
- What are the global sales for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)?
- What is Average Wholesale Price for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)?
Summary for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,069 |
| DailyMed Link: | MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) at DailyMed |
-patent-expirations.png "MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) drug patent expirations")
Recent Clinical Trials for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| U.S. Army Office of the Surgeon General | Phase 1 |
See all MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) clinical trials
Pharmacology for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
| Drug Class | Benzodiazepine |
US Patents and Regulatory Information for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rafa Labs Ltd | MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) | midazolam hydrochloride | SOLUTION;INTRAMUSCULAR | 216359-001 | Aug 8, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
